Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
Key facts
- Who runs it
- Shanghai Eye Disease Prevention and Treatment Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 108 people, planned
- Started
- 9 Dec 2024
- Planned end
- 9 Jun 2025
- Type of study
- Interventional, 9 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Repeated Low-level Red-light
- Red LED
- Record updated
- 4 December 2024
Who can take part
- Age
- 8 years to 10 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Age: 8-10 years old
- Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye
- signed informed consent and was able to participate in the study
Who cannot take part
- Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery
- Use of orthokeratology, atropine, multifocal frame glasses and other myopia control methods; children who are currently receiving atropine, orthokeratology, multifocal frame glasses and other myopia control treatment, can be enrolled after 2 weeks of treatment
- Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome
- Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc
- History of refractive surgery, internal eye surgery, laser therapy, vitreous injection, etc
- diabetes, hypertension and other systemic disorders
- History of use of retinal toxic drugs, such as hydroxychloroquine, etc
- Other reasons considered unsuitable for inclusion by the study physician, including but not limited to other ocular and systemic disease abnormalities
- Strabismus or other binocular vision abnormalities
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Myopia or choroidal thickness or retina
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.
The 9 groups in the trial
- Red light: 2.0 mW/twice dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 2.0 mW/once dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 1.0 mW/twice dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 1.0 mW/once dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 0.5 mW/twice dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 0.5 mW/once dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 0.3 mW/twice dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red light: 0.3 mW/once dailyTreatment being tested
Treatment: Repeated Low-level Red-light
- Red LED: twice dailySham treatment, for comparison
Treatment: Red LED
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Exploratory Study on the Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
- Criteria questions
- Built from NCT06717048, who can take part
- Record updated
- 4 December 2024